pharmaphorum November 30, 2023
Phil Taylor

FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year.

Bumpus is heading for the number two position at the FDA – second only to Commissioner Robert Califf, who announced the appointment on X (formerly Twitter) – just over a year after she joined the agency.

“As principal deputy commissioner, Namandjé will work closely with FDA leadership to develop, advance, and implement key public health initiatives, as well as to oversee the agency’s day-to-day functions,” said Califf in an email to staff.

“Chief among those priorities is the proposed reorganisation unifying the Human Foods Programme, creating a new model for the Office of Regulatory Affairs, and strengthening...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article